Archives

by in
Entry Author Date Location
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
Marina Biotech Adds $3.3M 11/08/10 Seattle
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
La Jolla Institute Nabs $12.6M RNAi Grant 10/08/10 San Diego
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends 09/23/10 Boston
Tekmira Gets $5.8M from Hana 09/22/10 Seattle
RXi, EyeGate Team Up 09/22/10 Boston
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
Lee Hood & Team Moving to South Lake Union, Mirina Vs. Marina, Trubion Gets Acquired, & More Seattle-Area Life Sciences News 08/19/10 Seattle
Quark Nabs Novartis Option Deal 08/18/10 San Francisco
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names 08/16/10 Seattle
Marina Gets RNAi Delivery Tools for $5M 07/28/10 Seattle
MDRNA Does Reverse Stock Split 07/21/10 Seattle
AVI Biopharma Wins Big Ebola Contract Worth up to $291M 07/16/10 Seattle
Tekmira Nails $140M Defense Contract to Make RNAi Drug for Ebola 07/15/10 Seattle
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
Two Ways to Spark More Life Science Innovation, and One Way IT Can Avoid Harming Medicine 06/17/10 National
AVI Biopharma Gets $18M Flu Contract 06/07/10 Seattle
Tekmira Expands Bristol Deal 05/10/10 Seattle
Novartis Buys More Alnylam Shares 04/26/10 Boston
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
AVI Biopharma Ousts CEO Les Hudson in Boardroom Coup 04/21/10 Seattle
Taligen Adds Maraganore to Board 04/15/10 Boston
Mersana Strikes Deal With Teva Worth up to $334M for Long-Lasting Cancer Drug 04/13/10 Boston
Biotech’s Second Big Win in Healthcare Reform: A Tax Credit Bonanza 04/08/10 National
SS&C Prices IPO, Amag Gets $60M from Takeda, Selecta Nabs $15M, & More Boston-Area Deals News 04/07/10 Boston
Jobster Gets New Owner, MDRNA Merges with Cequent and Teams Up with Pfizer, & More Seattle-Area Deals News 04/06/10 Seattle
Page 3 of 6 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.